Clinical Trials Logo

Clinical Trial Summary

The objective of this survey is to evaluate the safety and efficacy of fomepizole intravenous infusion in Japanese patients with ethylene glycol and methanol poisonings in daily medical practice.


Clinical Trial Description

Clinical studies for fomepizole intravenous infusion have not been conducted in Japan, and there are few reports of data on drug-use, including in the literature, in Japanese patients; therefore, an evaluation of the safety and efficacy of fomepizole intravenous infusion is required. This specified drug-use survey for fomepizole intravenous infusion (Fomepizole Intravenous Infusion 1.5 g "Takeda," hereinafter referred to as "the drug") was planned to evaluate the safety and efficacy of the drug in patients with ethylene glycol and methanol poisoning in daily medical practice. ;


Study Design


Related Conditions & MeSH terms

  • Ethylene Glycol Poisoning, Methanol Poisoning
  • Poisoning

NCT number NCT02415712
Study type Observational
Source Takeda
Contact
Status Completed
Phase
Start date January 27, 2015
Completion date June 30, 2022